CompletedNot Applicable

MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases

United States45 participantsStarted 2021-07-29

Plain-language summary

This is a pilot trial to assess feasibility and acceptability of MyVoice:Rheum vs. a patient pamphlet among female patients ages 18-44 (n=40) who receive rheumatology care. • Hypothesis: MyVoice:Rheum will be feasible and acceptable to patients who receive rheumatology care.

Who can participate

Age range18 Years – 44 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients must have at least one of four rheumatic diseases diagnosed by a rheumatologist: rheumatoid arthritis (RA), systemic sclerosis (SSc), myositis, Sjogren's syndrome, vasculitis, spondyloarthritis, and systemic lupus erythematosus (SLE). Patients must read and speak in English as a Spanish-language version of the tool has not yet been developed Access to a smart phone, personal computer, or tablet. Exclusion Criteria: * Women who have had prior hysterectomy or sterilization, or are pregnant.

What they're measuring

Acceptability of Intervention

Timeframe: T2 (within 24 hours of intervention and appointment)

Intervention Appropriateness Measure

Timeframe: T2 (within 24 hours of intervention and appointment)

System Usability Scale

Timeframe: T2 (within 24 hours of intervention and appointment)

Trial details

NCT IDNCT04879745

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

Results submitted2023-12-30

View on ClinicalTrials.gov More Rheumatic Diseases trials